Abstract:Aim: To investigate the inhibitory effects of heparin on PC-3M cells proliferation in vitro and B16-F10-luc-G5 cells metastasis in Balb/c nude mice and identify the protein expression patterns to elucidate the action mechanism of heparin. Methods: Human prostate cancer PC-3M cells were incubated with heparin 0.5 to 125 μg/mL for 24 h. The proliferation of PC-3M cells was assessed by MTS assay. BrdU incoporation and Ki67 expression were detected using a high content screening (HCS) assay. The cell cycle and apoptosis of PC-3M cells were tested by flow cytometry. B16-F10-luc-G5 cardinoma cells were injected into the lateral tail vein of 6-week old male Balb/c nude mice and heparin 30 mg/kg was administered iv 30 min before and 24 h after injection. The metasis of B16-F10-luc-G5 cells was detected by bioluminescence assay. Activated partial thromboplastin time (APTT) and hemorheological parameters were measured on d 14 after injection of B16-F10-luc-G5 carcinoma cells in Balb/c mice. The global protein changes in PC-3M cells and frozen lung tissues from mice burdened with B16-F10-luc-G5 cells were determined by 2-dimensional gel electrophoresis and image analysis. The protein expression of vimentin and 14-3-3 zeta/delta was measured by Western blot. The mRNA transcription of vimentin, transforming growth factor (TGF)-β, E-cadherin, and α v -integrin was measured by RT-PCR. Results: Heparin 25 and 125 μg/mL significantly inhibited the proliferation, arrested the cells in G 1 phase, and suppressed BrdU incorporation and Ki67 expression in PC-3M cells compared with the model group. But it had no significant effect on apoptosis of PC-3M cells. Heparin 30 mg/kg markedly inhibits the metastasis of B16-F10-luc-G5 cells on day 8. Additionally, heparin administration maintained relatively normal red blood hematocrit but had no influence on APTT in nude mice burdened with B16-F10-luc-G5 cells. Thirty of down-regulated protein spots were identified after heparin treatment, many of which are related to tumor development, extracellular signaling, energy metabolism, and cellular proliferation. Vimentin and 14-3-3 zeta/delta were identified in common in PC-3M cells and the lungs of mice bearing B16-F10-luc-G5 carcinoma cells. Heparin 25 and 125 μg/mL decreased the protein expression of vimentin and 14-3-3 zeta/delta and the mRNA expression of α v -integrin. Heparin 125 μg/mL decreased vimentin and E-cadherin mRNA transcription while increased TGF-β mRNA transcription in the PC-3M cells, but the differences were not significant. Transfection of vimentin-targeted siRNA for 48 h significantly decreased the BrdU incoporation and Ki67 expression in PC-3M cells. Conclusion: Heparin inhibited PC-3M cell proliferation in vitro and B16-F10-luc-G5 cells metastasis in nude mice by inhibition of vimentin, 14-3-3 zeta/delta, and α v -integrin expression.

Role of Vimentin in the Inhibitory Effects of Low-Molecular-Weight Heparin on PC-3M Cell Adhesion To, and Migration Through, Endothelium

Roles of vimentin and 14-3-3 zeta/delta in the inhibitory effects of heparin on PC-3M cell proliferation and B16-F10-luc-G5 cells metastasis

Effects of Low Molecular Weight Heparin on Leukocyte Adhesion and Expression of Intercellular Adhesion Molecule-1

Low molecular weight heparin nanoparticles inhibit proliferation of vascular smooth muscle cell in rabbits

Anti- adhesion effects of heparin on endothelial cells

Modified Heparins Inhibit Integrin Αiibβ3 Mediated Adhesion of Melanoma Cells to Platelets in Vitro and in Vivo

Low Molecular Weight Heparin (Lmwh) Improves Peritoneal Function And Inhibits Peritoneal Fibrosis Possibly Through Suppression Of Hif-1 Alpha, Vegf And Tgf-Beta 1

Alterations in the Intracellular Ca2+ Concentration and Vimentin in Endothelial Cells Following Tumor Cell‐endothelial Cell Interactions

The efficacy of low molecular weight heparin in sixty cancer patients with venous thromboembolism

Effect of Low-molecular-weight Heparin on the Survival in Malignant Tumor Patients with Venous Thromboembolism:a Meta-analysis

Anti-angiogenic activity and antitumor efficacy of amphiphilic twin drug from ursolic acid and low molecular weight heparin.

The Role of Heparin Binding Surfaces in the Direction of Endothelial and Smooth Muscle Cell Fate and Re-Endothelialization

Modified heparins inhibit integrin α<sub>IIb</sub>β<sub>3</sub>mediated adhesion of melanoma cells to platelets<i>in vitro</i>and<i>in vivo</i>

Development of Low Molecular Weight Heparin by H2O2/ascorbic Acid with Ultrasonic Power and Its Anti-Metastasis Property.

Perturbation of the Heparin/heparin-Sulfate Interactome of Human Breast Cancer Cells Modulates Pro-Tumourigenic Effects Associated with PI3K/Akt and MAPK/ERK Signalling

[Effects of Low Molecular Weight Heparin on Vascular Endothelial Growth Factor Expression of Early Diabetic Nephropathy].

The efficacy and safety of low-molecular-weight heparin use for cancer treatment: A meta-analysis

[The Effect of Intraperitoneal Heparin on Distribution of ACC-M in Lung and Liver].

Lentivirus-mediated Vimentin Gene Silencing Inhibits Invasion and Adhesion of Pancreatic Carcinoma Cells

The effects of low molecular weight heparin on allergic response

Influence of low-molecular-weight heparin on PAI-1 in rats with immune complexes nephritis